Clinical trial · Observational
Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiotherapy
EUS-Guided Fiducial Placement for Stereotactic Body Radiotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient enrollment.
Summary
Brief summary (as posted)
The purpose of this research study is to evaluate placing the radiation therapy markers (Fiducial) by using an endoscopic procedure. The endoscopic procedure is called an Endoscopic Ultrasound (EUS). This is a procedure using a special endoscope that has an ultrasound on the end. The ultrasound will allow the doctor's to see where the radiation therapy markers (Fiducial) is to be placed as outlined by the Radiation Oncologist.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endoscopic Ultrasound (EUS) for fiducial placement | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Subjects requiring fiducial placement
- description
- Endoscopic Ultrasound (EUS) for fiducial placement
- interventionNames
- Procedure: Endoscopic Ultrasound (EUS) for fiducial placement
Primary outcomes (1)
- measure
- Evaluation of the success and accuracy of endoscopic delivery of the Fiducials into pre-selected targets using dedicated EUS fiducial delivery system.
- timeFrame
- approximately one week
- description
- The outcome measure for this study is to determine: 1. The successful delivery, to the targeted tissue,of the fiducials through the fiducial delivery system, 2. The accuracy of the fiducial delivery into the targeted tissue and 3. to see if the fiducials can be visualized via Endoscopic Ultrasound (EUS), Fluoroscopy and/or CT scan. The success and accuracy of the delivery will be evaluated by Endoscopic Ultrasound, fluoroscopy and/or CT scan to determine if the fiducials are in the targeted tissue. The subject's Oncologist will inform the endoscopist of the targeted tissue that is to receive the fiducials.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 years or older, * Scheduled to undergo fiducial placement, * Subject must be able to give informed consent Exclusion Criteria: * Any contraindication to performing endoscopy, * Participation in another research protocol that could interfere or influence the outcomes measures of the present study, * The subject is unable/unwilling to give informed consent
References
Publications (0)
Data not yet available